Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

1630

Actual shortage: 192 (12%)
Anticipated shortage: 2 (0%)
Avoided shortage: 7 (0%)
Resolved: 1429 (88%)

Discontinuation Reports

237

To be discontinued: 3 (1%)
Discontinued: 234 (99%)
Reversed: 0 (0%)

Late reports

243 (13%)

Overdue reports

4 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMLODIPINE 10MG TABLET Resolved 2021-09-30 2021-10-07 146443
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-03-11 131676
ACT AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-05-06 131679
ACT AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-25 2021-05-20 136286
ACT AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Avoided shortage 2021-05-20 2021-07-08 139722
ACT AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-15 2021-09-09 142610
ACT AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2021-09-23 2021-10-14 146092
TEVA-ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896

Showing 1 to 20 of 1630

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65020
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65023
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-06-11 2020-06-11 117546
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-09-24 2020-09-24 124899
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION To be discontinued 2019-07-05 2019-07-05 88619
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-09-27 2019-10-01 94980
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-10-17 2019-10-17 96695
ZOLEDRONIC ACID INJECTION 5MG SOLUTION Discontinued 2017-06-27 2017-06-27 14030

Showing 221 to 237 of 237